Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-022456
Filing Date
2024-08-28
Accepted
2024-08-28 16:35:55
Documents
2
Period of Report
2024-08-26

Document Format Files

Seq Description Document Type Size
1 form3-08282024_080851.html 3  
1 form3-08282024_080851.xml 3 1687
2 ex24-08282024_080853.htm EX-24 4720
  Complete submission text file 0001415889-24-022456.txt   7944
Mailing Address C/O INTERMUNE, INC. 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Russell Angus C. (Reporting) CIK: 0001534002 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41608 | Film No.: 241255999

Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)